title: US national survey of physician practices for the secondary and tertiary prevention of ischemic stroke. Design, service availability, and common practices.
abstract: OBJECTIVE
  Stroke is largely a preventable disease. However, there are little data available concerning the use of stroke prevention diagnostic and treatment modalities by practicing physicians. These data are critical for the rational allocation of resources and targeting of educational efforts. The purposes of this national survey were to gather information about physicians' stroke prevention practice patterns and their attitudes and beliefs regarding secondary and tertiary stroke prevention strategies.
  
  
  METHODS
  We conducted a national survey of stroke prevention practices among a stratified random sample of 2000 physicians drawn from the American Medical Association's Physician Masterfile. The survey focused on the availability of services and the use of diagnostic and preventive strategies for patients at elevated risk of stroke.
  
  
  RESULTS
  Sixty-seven percent (n = 1006) of eligible physicians completed the survey. Diagnostic studies considered readily available by at least 90% of physicians included carotid ultrasonography, transthoracic echocardiography, Holter monitoring, and brain CT and MRI scans. MR angiography was perceived as being readily available by 68% and transesophageal echocardiography by 74% of respondents. Twelve percent of physicians reported cerebral arteriography and 10% reported carotid endarterectomy as not being readily available. Multiple logistic regression analyses showed that the availability of services varied with physician specialty (noninternist primary care, internal medicine, neurology, surgery), practice setting (nonmetropolitan versus small metropolitan or large metropolitan areas), and for carotid endarterectomy, region of the country (South, Central, Northeast, and West). The odds of carotid endarterectomy being reported as readily available were approximately 2.5 to 3.5 times greater for physicians practicing in the central, northeastern, and western regions compared with those practicing in the South, independent of practice setting and specialty. With regard to stroke prevention practices, 61% of physicians reported prescribing 325 mg of aspirin for stroke prevention, while 33% recommend less than 325 mg and 4% use doses of 650 mg or more. Seventy-one percent of physicians using warfarin reported monitoring anticoagulation with international normalized ratios, and 78% reported monitoring anticoagulated patients at least once a month. Fewer than 20% of physicians reported knowing the perioperative carotid endarterectomy complication rates at the hospital where they perform the operation themselves or refer patients to have the procedure done.
  
  
  CONCLUSIONS
  Although all routine and most specialized services for secondary and tertiary stroke prevention are readily available to most physicians, variation in availability exists. The use of international normalized ratios for monitoring warfarin therapy has not yet become universal. Physician knowledge of carotid endarterectomy complication rates is generally lacking. Depending on their causes, these problems may be addressed through targeted physician education efforts and systematic changes in the way in which services are provided.
authors.affiliation: Division of Neurology, Duke University, Durham, NC, USA.
authors.forename: L B
authors.initials: LB
authors.lastname: Goldstein
authors.forename: A J
authors.initials: AJ
authors.lastname: Bonito
authors.forename: D B
authors.initials: DB
authors.lastname: Matchar
authors.forename: P W
authors.initials: PW
authors.lastname: Duncan
authors.forename: G H
authors.initials: GH
authors.lastname: DeFriese
authors.forename: E Z
authors.initials: EZ
authors.lastname: Oddone
authors.forename: J E
authors.initials: JE
authors.lastname: Paul
authors.forename: D R
authors.initials: DR
authors.lastname: Akin
authors.forename: G P
authors.initials: GP
authors.lastname: Samsa
mesh_terms: D001241:Aspirin / Q000008:administration & dosage / Q000627:therapeutic use; D001291:Attitude of Health Personnel; D002545:Brain Ischemia / Q000175:diagnosis / Q000517:prevention & control* / Q000534:rehabilitation / Q000628:therapy; D002339:Carotid Arteries / Q000000981:diagnostic imaging; D002533:Cerebral Angiography; D002561:Cerebrovascular Disorders / Q000175:diagnosis / Q000517:prevention & control* / Q000534:rehabilitation / Q000628:therapy; D004452:Echocardiography; D017548:Echocardiography, Transesophageal; D004502:Education, Medical, Continuing; D015716:Electrocardiography, Ambulatory; D016894:Endarterectomy, Carotid / Q000009:adverse effects; D015276:Health Care Rationing; D006297:Health Services Accessibility; D006801:Humans; D018810:Magnetic Resonance Angiography; D008279:Magnetic Resonance Imaging; D008875:Middle Aged; D010820:Physicians; D010818:Practice Patterns, Physicians'; D011364:Professional Practice; D012307:Risk Factors; D014057:Tomography, X-Ray Computed; D014481:United States; D014859:Warfarin / Q000008:administration & dosage / Q000627:therapeutic use
chemical_list: D014859:Warfarin; D001241:Aspirin